Pacific Biosciences Nets $68M in New Financing | GenomeWeb

NEW YORK (GenomeWeb news) – Pacific Biosciences has raised $68 million in a round of financing from new and previous investors, bringing the total amount it has raised since the summer of 2008 to $188 million, the company said today.

The DNA sequencing technology developer plans to launch a commercial version of its single-molecule, real-time (SMRT) Sequencing System in the second half of 2010.

New investors joining this round of funding include the Wellcome Trust, Monsanto, and Sutter Hill Ventures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.